Bio-Techne Corporation

Equities

TECH

US09073M1045

Real-time Estimate Cboe BZX Other stock markets 12:56:16 2025-12-10 EST			5-day change	1st Jan Change
59.46 ^USD	+1.10%		-7.10%	-17.69%

12-09	Bio-Techne Launches the Enhanced Leo System Delivering Advanced Multiplexing and High-Throughput Protein Analysis	CI
12-09	Bio-Techne Corporation Presents at 53rd Annual Nasdaq Investor Conference, Dec-09-2025 09:30 AM

Transcript : Bio-Techne Corporation, Q3 2025 Earnings Call, May 07, 2025

Published on 05/07/2025 at 07:00 am EDT - Modified on 06/25/2025 at 07:03 pm EDT

S&P Capital IQ

Presentation Operator Message
Operator (Operator)

Good morning, and welcome to Bio-Techne Earnings Conference Call for the Third Quarter of Fiscal Year 2025. [Operator Instructions] I would now like to

This article is reserved for subscribers

Unlock the article : SUBSCRIBE!

Already a customer? Log In

Latest news about Bio-Techne Corporation

12-09	Bio-Techne Launches the Enhanced Leo System Delivering Advanced Multiplexing and High-Throughput Protein Analysis	CI
12-09	Bio-Techne Corporation Presents at 53rd Annual Nasdaq Investor Conference, Dec-09-2025 09:30 AM
12-03	Bio-Techne Corporation Presents at Citi Annual Global Healthcare Conference 2025, Dec-03-2025 03:15 PM
12-02	Bio-Techne Corporation Presents at Evercore 8th Annual Healthcare Conference, Dec-02-2025 08:20 AM
11-20	Bio-Techne Corporation Presents at Jefferies London Healthcare Conference 2025, Nov-20-2025 12:30 PM
11-20	Argus Adjusts Price Target on Bio-Techne to $68 From $65, Maintains Buy Rating	MT
11-18	Bio-Techne Corporation Presents at Stephens Annual Investment Conference 2025, Nov-18-2025 08:00 AM
11-18	Bio-Techne Licenses AI-Designed NovoBody Duo Molecules From Monod Bio	MT
11-18	Bio-Techne announces licensing agreement with Monod Bio	RE
11-11	Bio-Techne Corporation Presents at Stifel 2025 Healthcare Conference, Nov-11-2025 09:20 AM
11-10	Bio-Techne Corporation Presents at UBS Global Healthcare Conference 2025, Nov-10-2025 10:15 AM
11-06	Wells Fargo Adjusts Bio-Techne Price Target to $70 From $59, Maintains Overweight Rating	MT
11-06	Baird Adjusts Bio-Techne Price Target to $61 From $62, Maintains Neutral Rating	MT
11-06	Stephens Adjusts Bio-Techne Price Target to $70 From $65, Maintains Overweight Rating	MT
11-06	UBS Adjusts Price Target on Bio-Techne to $70 From $65, Maintains Buy Rating	MT
11-05	Tranche Update on Bio-Techne Corporation's Equity Buyback Plan announced on May 6, 2025.	CI
11-05	Evercore ISI Adjusts Price Target on Bio-Techne to $68 From $72	MT
11-18	Bio-Techne Corporation, Q1 2026 Earnings Call, Nov 05, 2025
11-05	Bio-Techne Corporation Declares Dividend for the Quarter Ended September 30, 2025, Payable on November 28, 2025	CI
11-05	Bio-Techne Corporation Reports Earnings Results for the First Quarter Ended September 30, 2025	CI
11-05	Bio-Techne misses quarterly sales estimates on weak biotech demand	RE
11-05	Bio-Techne Fiscal Q1 Adjusted Earnings Flat, Revenue Declines; Shares Down Pre-Bell	MT
11-05	Bio-Techne Q1 revenue misses estimates	RE
11-05	Earnings Flash (TECH) Bio-Techne Corporation Reports Q1 Revenue $286.6M, vs. FactSet Est of $291.3M	MT
11-05	Earnings Flash (TECH) Bio-Techne Corporation Posts Q1 Adjusted EPS $0.42 per Share, vs. FactSet Est of $0.42	MT